drugset / Trial / NCT00283543
Radiation With Concomitant and Then Sequential Temozolomide in Malignant Glioma
Non-randomizedSingle-groupOpen-labelTreatment
Summary
To determine the safety and efficacy of Gliadel 3.85% wafers plus surgery and radiation with Temozolomide
Timeline
- Start
- 2002-09
- Primary completion
- —
- Completion
- 2008-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gliadel Wafer | Unknown | — | — |
| Subject | Temozolomide | Small molecule | — | — |